XML 23 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHARE CAPITAL AND STOCK OPTIONS (Narrative) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 0 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended
Sep. 19, 2012
Sep. 30, 2012
Jun. 30, 2012
Jun. 30, 2012
Biopharmax [Member]
Sep. 30, 2012
Biopharmax [Member]
Sep. 30, 2012
Warrant [Member]
Investor [Member]
Stockholders Equity Note [Line Items]            
Number of warrants exercised   479,532        
Number of common stock shares issued related to warrants   287,483       688,139
Proceeds received from warrants           $ 1,229
Shares issued in advance for services       1,500,000    
Shares issued in advance for services, value, sold       5,071    
Advance payment for leasehold improvements   3,428 2,400   3,428  
Additional shares commited for issuance   28,860        
Class of Warrant or Right [Line Items]            
Costs related to private placement   2,694        
Units sold in public offering 8,000,000          
Public offering, number of shares per unit 1          
Public offering, number of warrants per unit 1          
Public offering, purchase price per unit $ 4.0          
Public offering, number of shares per one warrant 0.35          
Limited period, number of common stock options, underwriters 1,200,000          
Maximum of options and warrants 420,000          
Proceeds from issuance of shares $ 34,106          
Warrant exercise price per share $ 5.0